151 related articles for article (PubMed ID: 29714558)
1. Assessing Study Start-up Practices, Performance, and Perceptions Among Sponsors and Contract Research Organizations.
Lamberti MJ; Wilkinson M; Harper B; Morgan C; Getz K
Ther Innov Regul Sci; 2018 Sep; 52(5):572-578. PubMed ID: 29714558
[TBL] [Abstract][Full Text] [Related]
2. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
4. Benchmarking the Vendor Qualification Process.
Getz K; Wilkinson M; Turpen J; Salotti D; Rye K; Carnan E; Profit D
Ther Innov Regul Sci; 2020 Nov; 54(6):1349-1358. PubMed ID: 33258097
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials.
Dirks A; Florez M; Torche F; Young S; Slizgi B; Getz K
Ther Innov Regul Sci; 2024 May; 58(3):520-527. PubMed ID: 38366107
[TBL] [Abstract][Full Text] [Related]
6. A Study on the Application and Use of Artificial Intelligence to Support Drug Development.
Lamberti MJ; Wilkinson M; Donzanti BA; Wohlhieter GE; Parikh S; Wilkins RG; Getz K
Clin Ther; 2019 Aug; 41(8):1414-1426. PubMed ID: 31248680
[TBL] [Abstract][Full Text] [Related]
7. An Examination of eClinical Technology Usage and CDISC Standards Adoption.
Lamberti MJ; Kush R; Kubick W; Henderson C; Hinkson B; Kamenju P; Getz KA
Ther Innov Regul Sci; 2015 Nov; 49(6):869-876. PubMed ID: 30222377
[TBL] [Abstract][Full Text] [Related]
8. The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies.
Lamberti MJ; Kubick W; Awatin J; McCormick J; Carroll J; Getz K
Ther Innov Regul Sci; 2018 Nov; 52(6):778-783. PubMed ID: 29714579
[TBL] [Abstract][Full Text] [Related]
9. Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement.
Kurbegov D; Hurley P; Waterhouse DM; Robert NJ; Nowakowski GS; Thompson MA; Bruinooge SS; Schilsky RL; Byatt L; Dempsey K; Dawson C; Hofacker J; Liu J; MacDougall AK; Kim ES
JCO Oncol Pract; 2021 Jan; 17(1):41-51. PubMed ID: 33405975
[TBL] [Abstract][Full Text] [Related]
10. Contract research organizations in oncology clinical research: Challenges and opportunities.
Roberts DA; Kantarjian HM; Steensma DP
Cancer; 2016 May; 122(10):1476-82. PubMed ID: 27018651
[TBL] [Abstract][Full Text] [Related]
11. Taking the pulse of strategic outsourcing relationships.
Getz KA; Lamberti MJ; Kaitin KI
Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
[TBL] [Abstract][Full Text] [Related]
12. Contract research organizations (CROs) may be the next trend in clinical trials liability.
Valdes S; McGuire P
J Biolaw Bus; 2004; 7(3):11-5. PubMed ID: 15460602
[TBL] [Abstract][Full Text] [Related]
13. Continuous quality improvement in contract research organizations--the customer focus.
Sollecito WA; Kaluzny AD
Qual Manag Health Care; 1999; 7(3):7-21. PubMed ID: 10537463
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials and contract research organizations in India.
Mukherjee S
Clin Lab Med; 2012 Jun; 32(2):315-20. PubMed ID: 22727008
[TBL] [Abstract][Full Text] [Related]
15. What Drug Development Sponsors, Contract Research Organizations, and Investigators Can Do to Increase Diversity in Clinical Trials.
Symes YR; Modell JG
J Clin Pharmacol; 2020 Mar; 60(3):281-283. PubMed ID: 31608451
[No Abstract] [Full Text] [Related]
16. Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action.
Hirsch IB; Martinez J; Dorsey ER; Finken G; Fleming A; Gropp C; Home P; Kaufer DI; Papapetropoulos S
Clin Ther; 2017 May; 39(5):1064-1076. PubMed ID: 28413148
[TBL] [Abstract][Full Text] [Related]
17. Benchmarking the Study Initiation Process.
Lamberti MJ; Brothers C; Manak D; Getz K
Ther Innov Regul Sci; 2013 Jan; 47(1):101-109. PubMed ID: 30227494
[TBL] [Abstract][Full Text] [Related]
18. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
Shi YZ; Hu H; Wang C
Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
[TBL] [Abstract][Full Text] [Related]
19. Pirates of Clinical Trials.
Pergolizzi J; Pergolizzi C; LeQuang JAK
Cureus; 2023 Oct; 15(10):e47819. PubMed ID: 38022306
[TBL] [Abstract][Full Text] [Related]
20. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
